Tri Locum Partners LP Celldex Therapeutics, Inc. Transaction History

Tri Locum Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $1.74 Million - $2.83 Million	-62,460 Reduced 26.18%	176,109 $7.85 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $2.42 Million - $4 Million	106,421 Added 80.53%	238,569 $6.71 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $5.15 Million - $9.38 Million	-251,171 Reduced 65.53%	132,148 $3.56 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $10.6 Million - $15.1 Million	383,319 New	383,319 $13.1 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $5.08 Million - $9.82 Million	-175,305 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $442,510 - $755,750	-21,367 Reduced 10.86%	175,305 $5.86 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $3.18 Million - $5.88 Million	196,672 New	196,672 $4.05 Million

206

70.2M

1.46M

868K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.06B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.